GlycoForm's mission is to improve the therapeutic and clinical value of drugs through the design of sugars and their positioning on molecules to deliver the optimal activity.

GlycoForm delivers Novel Synthetic Glycotherapeutics

The approach developed by GlycoForm is to use synthetic glycosylation. The key benefit of this is the production of a homogeneous product in high yield which has the following advantages:

  • Product consistency, which in turn confers safety and regulatory advantages
  • Different sugars can be attached at any site chosen for glycosylation on the molecule, further extending the potential biological impact of glycosylation
  • A range of sugars can be introduced using a pure synthetic approach, or by using glycosyltranferases, or a combination of both. This flexibility extends the scope of the glycobiological effects that can be produced

GlycoForm will deliver Novel Synthetic Glycomolecules with enhanced activity.